Medifast, Inc. reports developments as a metabolic health and wellness company built around the OPTAVIA science-backed, coach-guided lifestyle system. Its updates center on revenue trends, gross margin, active earning coaches, coach productivity and the company's shift toward metabolic health amid changes in weight-loss demand and GLP-1 medication adoption.
Recurring company news also covers OPTAVIA program evidence, nutrition and habit-creation offerings, HSA/FSA reimbursement availability on select insurance plans, independent coach community initiatives, media content tied to metabolic health, and governance matters such as board nominations and stockholder cooperation agreements.
Medifast, Inc. (NYSE: MED) announced that CEO Dan Chard and CFO Jim Maloney will present at the 2022 ICR Conference on January 11, 2022, at 2:30 p.m. ET. The presentation will be live-streamed on Medifast's Investor Relations website and archived until January 25, 2022. Medifast is recognized for its OPTAVIA® health and wellness community, emphasizing lifelong transformation through healthy habits. The company has received accolades such as FORTUNE's 100 Fastest-Growing Companies and was named one of Forbes' 100 Most Trustworthy Companies in America.
Medifast (NYSE: MED) released a survey indicating that only 10% of U.S. adults successfully maintain their New Year's resolutions, with 47% breaking theirs within the first month. The intention to set resolutions has dropped to 44% in 2022 from 50% in 2021, attributed mainly to lack of motivation. The survey shows a shift towards manageable lifestyle changes; 58% of respondents prefer gradual habit changes, and 66% favor smaller daily adjustments over quick diets. Medifast's OPTAVIA® supports this approach through community and coaching.
Summary not available.
Medifast, Inc. (NYSE: MED) has declared a $1.42 quarterly cash dividend, payable on February 8, 2022, to stockholders of record by December 21, 2021. The company aims to maintain a quarterly dividend program, subject to the Board's discretion. Medifast is known for its health and wellness community, offering OPTAVIA® products and coaching. The company has been recognized in various industry rankings, including FORTUNE's 100 Fastest-Growing Companies list.
Medifast reported robust Q3 2021 results, showcasing a 52.3% revenue increase to $413.4 million compared to Q3 2020. Active OPTAVIA Coaches grew 44.9% to 61,000, with revenue per Coach rising 7.0% to $6,773. Net income surged 21.9% to $42.0 million, yielding an EPS of $3.56, up 22.3%. Despite these gains, gross profit margin slightly decreased to 74.3% and SG&A expenses climbed 57.9%. The company anticipates full-year revenue between $1.51 billion and $1.53 billion.
Medifast, Inc (NYSE: MED) will announce its third-quarter financial results for the period ending September 30, 2021, on November 4, 2021, after the market closes. The conference call, featuring CEO Dan Chard and CFO Jim Maloney, will begin at 4:30 p.m. ET, accessible via their website or by phone. Medifast is recognized for its OPTAVIA® health and wellness community, which has influenced 2 million lives, offering scientifically developed products and support for healthy habits.
Medifast (NYSE: MED) hosted its third annual Healthy Habits For All Week from September 20-26, 2021, aimed at improving health education and access in underserved communities. The event included employee volunteers distributing back-to-school bags and Chromebooks to local students in Baltimore. Medifast collaborated with nonprofits like No Kid Hungry, raising over $900,000 to provide up to 9 million meals for children in need. CEO Dan Chard emphasized the initiative's alignment with the company's mission to promote wellness among future generations.
Medifast (NYSE: MED) released survey findings indicating that support is essential for individuals pursuing health and wellness goals. Notably, 66% of U.S. adults reported that support has aided their journeys, while 81% believe having experienced support increases the likelihood of success in developing healthy habits. The survey also identified key support types: informational (75%), emotional (70%), and affirmational (70%). The OPTAVIA program emphasizes the importance of Coach support, aligning with these insights to foster client success.
Medifast, Inc. (NYSE: MED) announced a quarterly cash dividend of $1.42 per share, payable on November 8, 2021, to shareholders of record by September 21, 2021. The company aims to maintain a quarterly dividend program, yet future declarations depend on the Board of Directors' discretion. Medifast has established itself as a leader in the health and wellness sector, supporting clients through its OPTAVIA® platform. Factors influencing future dividend declarations include operational performance and market conditions.
Medifast, Inc (NYSE: MED) announced that its Chairman and CEO, Dan Chard, along with CFO Jim Maloney, will present at the Jefferies Virtual Fitness & Wellness Summit on September 15, 2021, at 11:00 a.m. ET. This presentation will be broadcast live via the Investor Relations section of Medifast's website and archived until September 29, 2021. Medifast is recognized for its OPTAVIA® program, which promotes healthy living through scientifically developed products and community support, impacting over 2 million lives.